Please login to the form below

Not currently logged in
Email:
Password:

AZD0914

This page shows the latest AZD0914 news and features for those working in and with pharma, biotech and healthcare.

Cubist antibiotic to get priority review in US

Cubist antibiotic to get priority review in US

It is the second boost for new antibiotics in the US this month after the FDA's decision to grant fast track status to AstraZeneca's AZD0914 for the sexually transmitted

Latest news

  • FDA fast-tracks new AstraZeneca antibiotic FDA fast-tracks new AstraZeneca antibiotic

    FDA. AZD0914 has shown promise as a treatment for the sexually transmitted infection (STI) uncomplicated gonorrhoea, which, like other infectious diseases, is growing increasingly resistant to existing antibiotics. ... AZD0914 is also classed as a

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics